ABSTRACT Several bacterial pathogens that cause severe infections in warm-blooded animals, including humans, have the potential to actively invade host cells and to efficiently replicate either in the cytosol or in specialized vacuoles of the mammalian cells. The interaction between these intracellular bacterial pathogens and the host cells always leads to multiple physiological changes in both interacting partners, including complex metabolic adaptation reactions aimed to promote proliferation of the pathogen within different compartments of the host cells. In this chapter, we discuss the necessary nutrients and metabolic pathways used by some selected cytosolic and vacuolar intracellular pathogens and -when available -the links between the intracellular bacterial metabolism and the expression of the virulence genes required for the intracellular bacterial replication cycle. Furthermore, we address the growing evidence that pathogen-specific factors may also trigger metabolic responses of the infected mammalian cells affecting the carbon and nitrogen metabolism as well as defense reactions. We also point out that many studies on the metabolic host cell responses induced by the pathogens have to be scrutinized due to the use of established cell lines as model host cells, as these cells are (in the majority) cancer cells that exhibit a dysregulated primary carbon metabolism. As the exact knowledge of the metabolic host cell responses may also provide new concepts for antibacterial therapies, there is undoubtedly an urgent need for host cell models that more closely reflect the in vivo infection conditions.
Metabolic Adaptations of Intracellullar Bacterial
Pathogens and their Mammalian Host Cells during Infection ("Pathometabolism") ABSTRACT Several bacterial pathogens that cause severe infections in warm-blooded animals, including humans, have the potential to actively invade host cells and to efficiently replicate either in the cytosol or in specialized vacuoles of the mammalian cells. The interaction between these intracellular bacterial pathogens and the host cells always leads to multiple physiological changes in both interacting partners, including complex metabolic adaptation reactions aimed to promote proliferation of the pathogen within different compartments of the host cells. In this chapter, we discuss the necessary nutrients and metabolic pathways used by some selected cytosolic and vacuolar intracellular pathogens and -when available -the links between the intracellular bacterial metabolism and the expression of the virulence genes required for the intracellular bacterial replication cycle. Furthermore, we address the growing evidence that pathogen-specific factors may also trigger metabolic responses of the infected mammalian cells affecting the carbon and nitrogen metabolism as well as defense reactions. We also point out that many studies on the metabolic host cell responses induced by the pathogens have to be scrutinized due to the use of established cell lines as model host cells, as these cells are (in the majority) cancer cells that exhibit a dysregulated primary carbon metabolism. As the exact knowledge of the metabolic host cell responses may also provide new concepts for antibacterial therapies, there is undoubtedly an urgent need for host cell models that more closely reflect the in vivo infection conditions. Metabolic adaptation reactions are common when prokaryotes interact with eukaryotic cells, especially when the bacteria are internalized by these host cells. Such adaptations lead to significant changes in the metabolism of both partners. While the final outcome may be sometimes beneficial (e.g., in case of insect endosymbiosis) or (mainly) neutral for the interacting partners (e.g., microbiota and their hosts) (1) (2) (3) , it is usually detrimental in infections of mammalian cells by intracellular bacterial pathogens. In this encounter, a host cell-defense program is initiated, including antimicrobial metabolic reactions aimed to damage the invading pathogen and/or to withdraw essential nutrients, while the intracellular pathogen tries to deprive nutrients from the host cell and to counteract the antimicrobial reactions, resulting in damaging of the host cell. Our knowledge of the metabolic adaptation processes occurring during this liaison and the link between these metabolic changes and the pathogenicity is still rather fragmentary. For these complex metabolic interactions, we coin the term "pathometabolism". Studies of pathometabolism are not only central for a deeper understanding of bacterial infections caused by intracellular bacterial pathogens, but may also provide promising bacterial and host cell targets for the development of novel antimicrobial therapeutic measures.
GENERAL CONSIDERATIONS The Intracellular Bacterial Pathogens
Intracellular bacteria that may cause severe infections in humans (which are exclusively discussed here), are characterized by their ability to actively invade human and other mammalian cells (and eventually also cells of lower eukaryotic organisms), efficiently replicate intracellularly, and finally exit the infected cells and reinfect new host cells. "Facultative intracellular" bacteria may grow intracellularly within suitable host cells or extracellularly in various natural and artificial environments. The so-called "obligate intracellular" bacteria are thought to exclusively replicate within appropriate host cells. However, recent investigations show that even these bacterial pathogens may thrive in axenic media (4) (5) . Within the infected host cells intracellular bacteria may replicate in specifically modified pathogencontaining vacuoles (PCV) (6) . Typical representatives of this group belong to the genera Salmonella, Mycobacteria, Brucella, Legionella, Coxiella, and Chlamydia. The other group of intracellular bacterial pathogens, including members of the genera Shigella, Listeria, Rickettsia and Franciscella, escapes into the host cell's cytosol where these bacteria actively replicate (6) .
All intracellular bacteria must import basic nutrients from the host cell, including one or more suitable carbon, nitrogen, and sulphur sources and metal ions. Some intracellular bacteria require, in addition, several amino acids, nucleotides, vitamins, fatty acids, and even adenosine triphosphate (ATP) and nicotinamide adenine dinucleotide (NAD). The cytosolically replicating intracellular bacteria obviously have direct access to these host nutrients that are either taken up or produced by the host cells. Pathogens residing in PCVs, on the other hand, must transport cytosolic host nutrients across the vacuolar membrane. Depending on the pathogen, this membrane may obtain nutrient transporters by fusion with endocytic vesicles, including lysosomes, (macro)pinosomes, or exocytic vesicles, that contain enzymes, transporters, and/or nutrients (7) (8) (9) (10) (11) (12) (13) .
Although intracellular bacteria seem to be optimally adapted to a specific intracellular host cell niche, bacteria normally replicating in PCV, such as Mycobacterium tuberculosis or Salmonella enterica serovar Typhimurium (14) (15) (16) (17) , can enter the cytosol under certain conditions and replicate in this host cell compartment. This compartment switching may even represent an important step in infections, e.g., as part of the evasion process (16, 18) . Vice versa, cytosolically replicating bacteria, such as Listeria monocytogenes, seem to be able to also replicate in specific vacuoles under special conditions (19) . These events show that at least some intracellular bacteria are able to obtain suitable nutrients that support their active intracellular growth in different host cell niches.
For optimal adaption to the (often varying) metabolic state of host cells, intracellular bacterial pathogens have acquired, in some cases, additional metabolic genes from other bacteria through horizontal transfer (20) (21) (22) or have deleted metabolic genes (present in their nonpathogenic relatives) that may be harmful for intracellular replication (23) (24) (25) (26) . But in general, the metabolic capacity of intracellular bacterial pathogens differs extremely, ranging from the presence of all basic catabolic and anabolic pathways (e.g., Salmonella serovars, Shigella spp.) to the extensive loss of catabolic reactions and most biosynthetic pathways (e.g., Rickettsia spp., Chlamydia spp.). This high metabolic variability among the intracellular bacterial pathogens (Figs. 1 and 2) already suggests that their nutritional requirements and metabolic adaptation strategies to the host cells must also differ considerably. Mammalian cells obviously offer appropriate growth conditions in the cytosol and in vacuolar compartments for these metabolically highly diverse intracellular bacteria.
There seems to be a close coordination between the metabolism of the intracellular bacterial pathogens and the expression of virulence genes that encode the factors required for the various steps of the intracellular bacterial life cycle (i.e., invasion, proliferation in specific host cell niches, evasion and reinfection of new host cells, or by cell-to-cell spread) (27) (28) (29) .
The metabolic activity of intracellular bacteria is also clearly dependent on the host cell metabolism, which in turn is subject to significant changes triggered during infection by the intracellular pathogen, e.g., by the secretion of specific virulence factors and/or effector proteins (30) (see below).
Of course, the adequate supply of nutrients does not suffice to make the host cell an appropriate growth niche for an intracellular pathogen. Common and pathogenspecific metabolic reactions are also necessary to counteract the compartment-specific host cell defense mechanisms (see below) that otherwise would restrict the intracellular bacterial pathogen's ability to thrive (31) (32) . Common regulatory devices exist in mammalian cells that control both metabolic pathways and defense mechanisms (33) . Their inactivation by the intracellular pathogens might coordinate acquisition of nutrients from the host cell and resistance to host defense mechanisms (see below). Solid arrows indicate reversible (double-headed arrows) and essentially irreversible (single-headed arrows) reactions of glycolysis and gluconeogenesis (GL/GN), red arrows), pentose phosphate pathway (PPP, blue arrows), Entner-Doudoroff pathway (ED, orange arrows), the tricarboxylic acid cycle (TCA). The irreversible reactions involved in GN are marked by dotted-framed boxes: fbp for phosphofructo-1,6-bisphosphatase, pps for PEP synthase, and pckA for PEP carboxykinase. Broken black arrows depict anaplerotic reactions: GS for glyoxylate shunt, pycA for pyruvate carboxylase, ppc for PEP carboxylase; pckA for PEP carboxykinase, and maeA (sfcA) for malate enzyme. Yellow boxes and arrows mark major carbon and energy substrates and black-framed boxes mark the biosynthesis of amino acids, vitamins, nucleotides, cell envelope components, and fatty acids/lipids as well as the major sites of ATP production. Thus, common and indispensible properties of all intracellular bacteria that successfully proliferate within mammalian cells are the ability to take up and utilise appropriate host cell nutrients and to withstand the antimicrobial actions of the host cells. This ability is certainly not a common feature of all bacteria that eventually enter mammalian cells (34) , but seems to be the evolutionary result of a fine-tuned interconnection between the host-cell-adapted intracellular metabolism of the pathogen, the metabolism-dependent expression of virulence genes and the infection-adapted metabolism of the host cell.
Although we are still far away from the understanding of this complex interconnection, some progress has been made (especially with some model pathogens) by the introduction of new techniques, such as comparative transcriptome, proteome and metabolome analyses, 13 C-isotopologue profiling, and determination of metabolic reactions and fluxes using nuclear magnetic resonance (NMR), mass spectroscopy (MS), secondary-ion mass spectroscopy, and Raman microspectrometry; for recent reviews, see (27-28, 30, 35-38) .
Mammalian Cells Acting as Hosts for Intracellular Bacterial Pathogens
Phagocytes, especially dendritic cells (DC) and macrophages (MΦ), are often the first host cells encountered by intracellular bacterial pathogens during infection. These highly heterogeneous hematopoietic cells, found in nearly every tissue of the body (39) , are characterized by a particularly high antimicrobial capacity, including production of reactive oxygen species (ROS) and reactive nitrogen intermediates (RNI). Synthesis of these antimicrobial agents is induced via the classical activation pathway (40) (41) by microbial surface components (e.g., lipopolysaccharides [LPS] and other pathogenassociated molecular pattern [PAMP] molecules). These host cells also possess constitutive mechanisms to derive intracellular pathogens of required nutrients (42) , including expression of the divalent cation transporter Nramp1, leading to iron depletion (43) and interferon (IFN)-γ-induced activation of indoleamine 2,3-dioxygenase which degrades tryptophan, leading to tryptophan starvation (44) . As already stated above, successful intracellular pathogens must overcome (at least partially) these antimicrobial host cell activities.
The infected DC and MΦ may carry the intracellular bacteria to peripheral organs where they may invade new host cells, including epithelial cells, endothelial cells, hepatocytes, etc., either by cell-to-cell spreading (45) or by release from the carrier cells and re-infection of new host cells (16, 18) . The mechanisms by which intracellular bacteria, especially vacuolar pathogens, are released from primary infected cells are subject of extensive current research (16, (46) (47) . Active replication of intracellular bacteria represents a heavy metabolic burden for the infected cell, to which the host cell responds with general and specific metabolic changes. Compared to the progress concerning the metabolic adaptations of the intracellular pathogens, the knowledge of the metabolic host cell responses triggered by intracellular pathogens is still rather sketchy (30) . There are, indeed, several obstacles that hamper the investigation of the metabolic host cell responses. A major problem is the nature of the model host cells, including mammalian cancer cell lines, protists, or invertebrate cells, which are typically applied to in vitro infection studies. Compared to the slowly proliferating primary host cells invaded by the bacterial pathogens under in vivo conditions (e.g., MΦ, epithelial cells, endothelial cells, etc.), the in vitro-used cancer cells have a highly altered carbon metabolism (48) (49) , which may lead to enhanced glucose and/or glutamine uptake, induced (aerobic) glycolysis and/or glutaminolysis, reduced tricarboxylic acid (TCA) cycle, reduced aerobic respiration, high lactate production, and increased anabolic activities (e.g., biosynthesis of lipids, proteins, and nucleotides). The reason for this metabolic dysregulation in the most frequently used mammalian cell lines are mutations in tumour suppressors (e.g., p53) or oncogenes (e.g., c-Myc, HIF-1) that function also as regulators of the metabolism in mammalian cells (see below) as well as mutations in different enzymes associated with the tricarboxylic acid (TCA) cycle (50) (51) (52) . Intracellular bacteria will therefore encounter in these host cells completely different energy and nutrient conditions than in the target cells that they invade during infection. Possible activation of metabolic host cell reactions triggered by the intracellular bacteria may therefore not be detected in such model host cells, unless the metabolic changes are extremely pronounced. Protist and invertebrate infection models must also be critically assessed with respect to metabolic host responses since these cells often show different nutritional conditions and metabolic control mechanisms and, therefore, such metabolic data do not necessarily resemble the metabolic responses triggered by intracellular pathogens in mammalian cells.
Some Basic Aspects of the Mammalian Cell Metabolism
The metabolism of mammalian cells occurs in different compartments. The major catabolic reactions, essential for bioenergetic and biosynthetic processes, take place in the cytosol (glycolysis, oxidative pentose-phosphate pathway) and in mitochondria (tricarboxylic acid [TCA] cycle, glutaminolysis, β-oxidation). The inner mitochondrial membrane is also the site of the electron-transfer chain leading to oxidative phosphorylation. The anabolic reactions (gluconeogenesis, biosyntheses of amino acids, nucleotides, and fatty acids/lipids) occur mainly in the cytosol. There is an extensive exchange of certain metabolites between these two compartments followed by metabolic reactions in the cytosol, e.g., transport of citrate from mitochondria into the cytosol and conversion to oxaloacetate and acetyl-CoA by the cytosolic ATP-dependent citrate lyase, transport of malate and conversion to pyruvate and CO 2 by the cytosolic malic enzyme (Fig. 3a) . Common cellular regulators, including tumor suppressors and oncogenes, are involved in the orchestration of the entire cell metabolism (53) (54) . A simplified overview on these metabolic processes and their regulation in mammalian cells is given in Figs. 3b and 3c .
In addition, several other membrane-surrounded vesicles are involved in the metabolic processes. The peroxisomes are metabolically linked to mitochondria as both organelles are involved in β-oxidation of fatty acids and implicated in the production of ROS. However, peroxisomes are not associated with energy production, but rather involved in detoxification processes. Other vesicles contain digestive enzymes (lysosomes, ASMscience.org/MicrobiolSpectrum Main catabolic and anabolic pathways, including glycolysis (GL, red solid arrows) with lactose formation (red broken arrows), pentose-phosphate pathway (PPP, blue arrows) in the cyctosol, TCA cycle in the mitochondria and associated cytosolic reactions (black arrows), and glutaminolysis (purple arrows); catabolic breakdown of amino acids and fatty acids are indicated by dotted arrows. The reactions indicated by the green arrows are two anaplerotic reactions (catalysed by PCK and PYC). The starting points for the biosynthesis of the "non-essential" amino acids, nucleotides and fatty acids/lipids are schematically indicated by broken arrows. (b) Regulation of glucose uptake, glycolysis and pentose-phosphate pathway and (c) of the TCA cycle, glutaminolysis, aerobic respiration, and lactate production by general transcription factors, tumor suppressors, and oncogenes. Activation of the target enzymes (yellow boxes) are shown by green pointed arrows and inhibition by the red symbol. Explanations and abbreviations: Fru-2,6P: fructose 2,6-bisphosphate, the formation of which is catalysed by the fructokinase 2 (PFK2); Fru-2,6P activates fructokinase 1(PFK1); ACL: cytosolic ATP-dependent citrate lyase; ICD-2: cytosolic NADP-dependent isocitrate dehydrogenase; ME: cytosolic malate dehydrogenase (malic enzyme); GLS: glutaminase; HIF-1: hypoxia-inducible factor1; p53: tumor suppressor protein 53 encoded by the gene TP53; TIGAR: TP53-inducible glycolysis and apoptosis regulator; PTEN: phosphatase and tensin homolog; mTORC1: mammalian target of rapamycin complex 1; PI3K/ Akt: phosphoinositide-dependent kinase-1/protein kinase B. For further details regarding the complex regulation circuit, see (30, 54) and further references cited there. doi:10.1128/microbiolspec.MBP-0002-2014.f3 autophagosomes) or store enzymes, transporters, and other biomolecules for secretion to the cell's exterior (secretory vesicles).
Selected Intracellular Bacterial Pathogens
As already mentioned above, intracellular bacterial pathogens may differ extremely with respect to their metabolic properties. The pathogens that we discuss in the following belong to either the "vacuolar" or the "cytosolic" group. For each group, we selected three model bacteria with very different metabolic capacities (ranging from complete prototrophy to middle and high auxotrophy). The cytosolic group includes Shigella flexneri (S. flexneri) and the closely related enteroinvasive E. coli (EIEC), Listeria monocytogenes (L. monocytogenes), and Rickettsia prowazekii (R. prowazekii). The phagosomal group includes Salmonella enterica serovar Typhimurium (S. typhimurium) replicating in the Salmonella-containing vacuole (SCV), Legionella pneumophila (L. pneumophila) replicating in the Legionellacontaining vacuole (LCV), and Chlamydia trachomatis (C. trachomatis) replicating in the so-called "inclusion".
Many relevant in vitro infection studies with the selected intracellular bacteria use established mammalian cell lines as host cells, and hence the following discussion is based to a considerable extent on results obtained with such cells. As outlined above, we are fully aware of the problems associated with the use of cancer cells when studying the intracellular metabolism of human bacterial pathogens (30) and especially the metabolic host responses to such infections. But we will emphasize the limits of these model systems and-wherever possiblecompare the in vitro results with corresponding in vivo data, obtained in appropriate animal models.
Intracellular Bacterial Pathogens
Replicating in the Cytosol S. flexneri and EIEC Metabolic adaptations of intracellular S. flexneri and EIEC These two highly related enterobacteriaceae are typical food-borne intracellular pathogens causing a severe diarrheal disease in humans that is characterized by the invasion and destruction of the colonic mucosa (55) . After invasion of intestinal epithelial cells, these bacteria replicate in the cytosol of the host cells (56) . They produce numerous effector proteins, secreted by a type III secretion system (T3SS), that are important virulence factors essential for invasion, intracellular replication, and cell-to-cell spread (57 , and the main anaplerotic reactions, including the glyoxylate shunt (GS), the malic enzyme (encoded by maeA), phosphoenolpyruvate (PEP) carboxy kinase (pckA), and PEP carboxylase (ppc). The biosynthetic pathways for all anabolic monomers (amino acids, vitamins and other co-factors, nucleotides, fatty acids, lipids) are functional (Fig. 1a) . Accordingly, both pathogens are able to grow in vitro in minimal media supplemented with a single suitable carbon source under aerobic and anaerobic conditions. Glucose is a preferred carbon source for growth, taken up by Shigella/EIEC mainly by two PEPdependent phosphotransferase systems (PTS); PtsG/Crr and ManXYZ (58) . Glucose 6-phosphate (glucose-6P) is transported by the UhpT transporter (59) . In both enterobacteria, the uhpT gene is under the control of a complex two-component system (uhpABC) and carboncatabolite repression (60) . Transcription of uhpT is therefore very low in the presence of glucose. Both pathogens can catabolize various C 2 -, C 3 -, C 4 -, and C 5 -substrates and, hence, fatty acids, glycerol, pyruvate, lactate, and C 4 -dicarboxylates may be used as carbon substrates under in vitro culture conditions.
Early information on the intracellular carbon metabolism of Shigella derives from (established) cell culture studies using differential gene-expression profiling, as well as from animal infection experiments applying mutants defective in specific catabolic or anabolic reactions (61) (62) (63) (64) . These studies suggested that as S. flexneri replicates in the cytosol, expression of the genes encoding the glucose transporters (ptsG/crr and manXYZ) were down-regulated, while those of uhpT-, glpF-, and ugp-encoding transporters for glucose-6P, glycerol, and glycerol 3-phosphate, respectively, were up-regulated. These genes are, however, subject to catabolite repression control and their up-regulation under intracellular conditions could simply reflect the lower glucose concentration within the host cells compared to the reference culture medium used. Indeed, a uhpT mutant showed wild-type replication in Henle cells (61) . The glycolysis genes were down-regulated, while those for gluconeogenesis (fbp and pps) were up-regulated, suggesting gluconeogenic substrate(s) as carbon source for cytosolically replicating Shigella.
However, 13 C-profiling studies using external [U-
13
C 6 ]glucose as major carbon source for Caco-2 cells infected with two different EIEC wild-type strains and
ASMscience.org/MicrobiolSpectrummutants impaired in transport of glucose and glucose-6P transport strains, showed that glucose, but not glucose-6P, is the preferred carbon source for intracellular EIEC in these host cells (65) . The 13 C-isotopologue profiles of amino acids deriving from intermediates of the glycolytic and TCA pathways suggested that glucose is catabolized through GL, PPP, and the TCA cycle in intracellularly replicating EIEC. However, in the absence of glucose, alternative carbon compounds, most likely C 3 -compounds such as glycerol and/or glycerol-3P, were used instead (65) . The exclusive consumption of these carbon sources requires gluconeogenesis.
A link between control of carbon metabolism and virulence gene expression by the carbon consumption regulators CsrA and Cra has been demonstrated (66) . CsrA acted as posttranscriptional activator of GL and repressor of gluconeogenesis (67), whereas the transcriptional regulator Cra had the opposite effect (68) . A csrA mutant showed decreased and a cra mutant increased invasion of Shigella in Henle cells, while both csrA and cra mutations seemed to inhibit the subsequent intracellular growth of Shigella (66) . These data suggest a positive role of GL in invasion, possibly by affecting activity and expression, respectively, of the virulence gene regulators VirF and VirB through product(s) of these metabolic pathways (66) . The inhibitory effect of csrA and cra mutations on intracellular growth suggests that both GL and gluconeogenesis are necessary and hence different carbon substrates may be used by Shigella in course of the intracellular replication cycle.
The choice of the carbon source seems to be also important for the capacity of de novo synthesis of anabolic monomers, such as amino acids and nucleotides, under intracellular conditions. An EIEC wild-type strain growing in Caco-2 epithelial cells and supplied with external [U- 13 C 6 ]glucose as major carbon source (65) incorporated 13 C-label into all amino acids (albeit to a different extent). The in vitro and in vivo observed virulence attenuation of aroB-D (and also of guaBA and thyA) mutants of S. flexneri, also suggested that biosynthesis of aromatic amino acids (but also of nucleotides) is essential for full virulence of Shigella (64, (69) (70) . In contrast, a glucose-uptake mutant whichas stated above-consumes C 3 -substrates, grew considerably slower than the wild-type strain in Caco-2 cells and incorporated 13 C-label only into Ala, Asp, Glu, Ser, Gly and Val. Apparently, all other amino acids were taken from the host under these conditions. Notably, the de novo synthesized amino acids (in contrast to the imported amino acids) required only one single step in their biosynthesis using a catabolic intermediate from the glycolytic or the TCA pathway, respectively, without ATP consumption.
Metabolic host cell responses triggered by intracellular S. flexneri
Shigella infection of established epithelial cells (HeLa and HCT116 cell lines) promotes p53 degradation by the calpain protease, which is activated by the virulence effector protein VirA (71) . The effect of this process on necrosis and apoptosis of the Shigella-infected cells was extensively analyzed, but not its probable impact on host cell metabolism. However, the expected increase in glucose uptake and glycolysis due to the loss of p53 may not be seen (as mentioned above) in the cancer cell lines used in this study, because of the already enhanced glucose metabolism of these cells (30) . Induction of glucose uptake in Shigella-infected primary intestinal epithelial cells due to loss of p53 would certainly favor the above described metabolism of intracellular Shigella.
Because of the narrow range of hosts that are susceptible to Shigella infection, robust data on in vivo metabolism of Shigella do not exist. A recent study that analyzed the proteome of Shigella dysenteriae isolated from the large bowel of infected gnotobiotic piglets came to the conclusion that the bacteria switch to an anaerobic metabolism accompanied by a strongly reduced TCA cycle (72) . However, it remained unclear in this study whether the majority of the bacteria analyzed replicated within epithelial cells or extracellularly in the bowel.
Listeria monocytogenes
Metabolic adaptations of intracellular L. monocytogenes L. monocytogenes is a Gram-positive bacterial pathogen that survives and replicates, like all other Listeria species, as a saprophyte in natural environments (73) . But L. monocytogenes is also capable of causing serious systemic infections in susceptible individuals with the help of a number of virulence factors that are absent in the non-pathogenic Listeria species; for recent reviews see (74) (75) . All listerial species may take up and utilize amino acids, C 3 -, C 4 -, and C 5 -carbon substrates, as well as many different carbohydrates (including glucose) via a large set of PEP-dependent transferase systems (PTS) (76) . In contrast to the non-pathogenic species, L. monocytogenes can also import phosphorylated hexoses by the phosphate antiporter UhpT (Hpt). The gene for this transporter (uhpT) is under the control of PrfA, the major transcriptional regulator of most listerial virulence genes (77) . Glucose and glucose-6P can be degraded via the intact glycolytic and pentose-phosphate pathway. The citrate cycle is, however, disrupted, lacking functional oxoglutarate dehydrogenase and malate dehydrogenase (78). Generation of oxaloacetate seems to occur exclusively by the ATP-dependent pyruvate carboxylase (PycA) (79) . Asp is not taken up by L. monocytogenes and hence can not fill-in oxaloacetate (79) . Gluconeogenesis starting from C 3 -and C 4 -components, but not from acetate (acetyl-CoA) is possible since PEPsynthetase (but not PEP carboxykinase) and phosphofructo-1,6-bisphosphatase (BFP) are present, and malic enzyme can convert malate to pyruvate (Fig. 1b) . Indeed, L. monocytogenes is able to grow in defined minimal media (80-82) with a variety of carbohydrates and glycerol and, to a lesser extent, also with pyruvate and malate as sole carbon sources. In contrast, efficient growth with one or more amino acids as sole carbon source does not occur (83) . Even with the above-mentioned growthsupporting carbon sources, proliferation of L. monocytogenes occurs only when a defined culture medium is supplemented with the three branched-chain amino acids (BCAA); Leu, Ile, and Val, the sulfur-containing amino acids, Met and Cys, and Arg together with the vitamins riboflavin, biotin, thiamine, and thioctic acid (80) . The requirement of the latter vitamins is due to the lack of necessary genes for their biosynthesis. The need for the amino acids is more unexpected, as all genes encoding the enzymes for the biosynthesis of these amino acids are present (84) and expressed under appropriate conditions (85) . We assume that shortage of essential biosynthetic intermediates might be the reason for the dependency on the BCAAs, Arg, Cys, and Met, i.e., limitation of pyruvate (necessary for the generation of oxaloacetate and acetyl-CoA, which are important for maintaining the truncated TCA cycle) and succinylCoA might be responsible for the failure of BCAA and Arg biosynthesis, respectively, while the missing sulfurreductase leads to the lack of the necessary sulphide necessary for de novo Cys (and hence Met) biosynthesis.
There is an obvious link between the listerial metabolism and the expression of the PrfA-dependent virulence genes (27, 29, 86) . Activity of PrfA, the major transcriptional regulator of the listerial virulence genes (87) , is low in rich culture media or in presence of carbohydrates (especially glucose and cellobiose) in defined minimal media as major carbon and energy sources, but high in presence of glycerol (82, 88 ). The precise activation mechanism of PrfA is still poorly understood (89) . In addition, the isoleucine response regulator CodY of Gram-positive bacteria (90) was shown to control prfA gene expression, thus linking synthesis of PrfA (and hence of virulence gene expression) to metabolic conditions, especially to the cellular BCAA concentration (86) .
Until now, the intracellular metabolism of L. monocytogenes was mainly studied in established epithelial and macrophage cell lines and in primary murine bone marrow-derived macrophages (BMM) that were infected with L. monocytogenes wild-type strains or mutants defective in the transport or catabolism of different carbon sources (36, (85) (86) (91) (92) (93) (94) . The conclusions drawn from these studies concerning the intracellular metabolism of L. monocytogenes are based on transcriptome, proteome, and 13 C-isotopologue analyses. Some interesting data concerning the listerial intracellular metabolism derived from recent in vivo studies (using a mouse-infection model), although the focus of these studies was primarily on other aspects of L. monocytogenes pathogenicity (95) (96) .
Together, these studies showed that the intracellular metabolism of L. monocytogenes relies on different carbon and nitrogen sources, which the host cell's cytosol provides in mostly limited and, apparently, host cell-specific concentrations (85, 91, 94) . Host-derived glucose 6-phosphate (G6P) and glycerol seem to be preferential carbon sources when the listeriae grew intracellularly in epithelial cells and macrophages, as shown (a) by the 13 C-isotopologue distribution in certain amino acids in the presence of uniformly labeled 13 C-glucose (93), (b) by the upregulation of the genes encoding G6P transport (i.e., uhpT), as well as uptake and catabolism of glycerol (i.e., glpF, glpK, and glpD) (85-86, 91, 95-96) , and (c) by the attenuation of intracellular replication of mutants defective in uptake or catabolism of these carbon substrates (36) (T. Fuchs, personal communication).
However, a mutant unable to grow with glycerol and G6P was still able to replicate-albeit at a reduced growth rate-in these epithelial and macrophage cells, and the 13 C-isotopologue analysis of the labeled amino acids suggests that either glucose or host cell-derived glucose catabolic intermediates (other than glycerol) can be used by the intracellular listeriae under these conditions (T. Fuchs, personal communication). There is circumstantial evidence (deriving mainly from transcriptome and proteome data) that the oxidative part of the PPP rather than glycolysis is preferentially used for degradation of G6P, but also the non-oxidative part of PPP appears to be up-regulated. Expression of the glycolytic genes seems to be initially reduced but is resumed at a later stage in the intracellular replication cycle ASMscience.org/MicrobiolSpectrum (85, (91) (92) . Whether the increased expression of the genes for the glycolytic enzymes in this state is necessary for catabolism of carbohydrates or for gluconeogenesis (when glycerol is used) remains an open question. The residual part of the disrupted TCA cycle (from oxaloacetate to oxoglutarate) is active as shown by the 13 C-isotopologue profiling data (93) 
These data suggest that more than one carbon compound is used by L. monocytogenes when the bacteria grow in the cytosol of mammalian host cells. This finding raises the interesting question whether these carbon substrates are used successively depending on their available concentration within the host cell and/or their efficiency as carbon and energy source or whether the carbon substrates are co-metabolized at the same time, serving either as energy source(s) or as producers of intermediates for indispensible anabolic processes (see also discussion below).
As discussed above, L. monocytogenes has the genes encoding the biosynthetic pathways for all amino acids suggesting that de novo synthesis of all amino acids should be, in principle, possible. Yet, listerial amino acid and oligopeptide transporters were shown to be important for intracellular replication of L. monocytogenes (36, 97) and genes encoding these transporters were induced in intracellularly growing L. monocytogenes (85, 91) . When a mixture of all 13 C-labeled amino acids (in presence of unlabeled glucose) was added to L. monocytogenes-infected epithelial cells, all labeled amino acids were taken up and incorporated into protein by the host cells and also-with the exception of Aspby the intracellular listeriae. However, little turnover of these amino acids was observed, suggesting that the host amino acids were primarily used for protein biosynthesis and hardly catabolized by the intracellular listeriae (T . Fuchs, personal communication) .
Ala, Asp, and Glu, the biosynthesis of which requires solely transamination of the central catabolic intermediates pyruvate, oxaloacetate, and oxoglutarate, respectively, were efficiently synthesized de novo by intracellular L. monocytogenes. At lower efficiency, de novo biosynthesis was also observed for Ser, Gly, Thr, and Val, which requires only a single catabolic intermediate (3-phosphoglycerate, oxaloacetate, and pyruvate, respectively) and a rather short biosynthetic pathway. All other amino acids, including His, Met, Leu, Ile, and the aromatic amino acids were not synthesized de novo under these conditions. This finding seems to contradict transcriptome data which indicated that transcription of the listerial genes encoding the enzymes for the biosynthesis of these latter amino acids is induced in intracellular L. monocytogenes (85-86, 91) . Apparently, the biosynthetic pathways for these amino acids are derepressed on the transcriptional level at the low glucose level but either translation of the transcripts is inhibited or-more likely-essential substrates or critical co-factors (such as ATP and NAD) required for their biosynthesis are limited. This example shows again the need of more than one analytical method for obtaining reliable data on the intracellular metabolism of bacterial pathogens.
The few in vivo data on intracellular listerial metabolism, obtained mainly by transcriptome analysis of L. monocytogenes isolated from infected mice (95) (96) , were basically in line with the corresponding transcription data obtained by the in vitro cell culture experiments described above. This might be surprising in light of the dysregulated carbon metabolism of the cell lines used for the in vitro infection studies compared to the tightly regulated host cells which L. monocytogenes encounters during in vivo infection. However, a recent 13 C-profiling study which compared the metabolism of L. monocytogenes in primary bone marrow-derived macrophages (BMM) and in cells of the murine macrophage cell line J774A.1 (94) showed an almost identical intracellular listerial carbon metabolism in both host cell sytems.
Metabolic host cell responses triggered by intracellular L. monocytogenes
None of the genes involved in host cell metabolism was significantly altered in the human macrophage-like cell line THP-1 upon L. monocytogenes infection (98) which is likely due to the already enhanced carbon metabolism of the THP-1 cancer cells. Yet, a L. monocytogenes infection strongly changes the metabolism of primary host cells, especially when the bacteria are internalized (30, 94, 99) . Comparative 13 C-isotopologue studies, using uniformly 13 C-labeled glucose or 13 C-labeled glutamine as carbon sources in infection assays of primary murine bone marrow-derived macrophages (BMM) and of murine macrophage-like J774A.1 cells (94), showed high induction of glucose uptake and of glycolysis in BMM upon infection, but not in the J774A.1 cells (which already exhibit dysregulated glucose transport and glycolysis). As already described above, the thereby enhanced glucose catabolism of the BMM apparently allows a similarly efficient proliferation of the intracellular listeriae in BMM as in J774A.1 cells. These in vitro data, obtained with primary host cells, are in accord with results deriving from in vivo studies which analyzed the transcript profiles of the intestinal epithelia of mice expressing humanized E-cadherin (99) . These studies also revealed that transcription of most glycolysis genes is enhanced upon L. monocytogenes infection. Interestingly, the gene encoding host cell hexosekinase II (hkII) showed the highest increase (about 10-fold), which suggests that glucose taken up is mostly phosphorylated by this enzyme. As discussed above, the thereby generated glucose-6P is an important carbon substrate for intracellular L. monocytogenes in epithelial cells and macrophages (77, 93) . These and other metabolic host responses (30, 99) appear to be triggered by the cytosolic bacteria since a noninvasive inlA, inlB double mutant of L. monocytogenes did not cause the up-regulation of these metabolic genes. The listerial (virulence?) factors causing these changes of the host cell metabolism are still unknown.
Rickettsia prowazekii (R. prowazekii) Metabolic adaptations of intracellular R. prowazekii
The genus Rickettsia comprises a variety of obligate intracellular pathogenic species (100). Among those, R. prowazekii, which is a member to the typhus group (TG) of Rickettsia species and transmitted from the human body louse to humans, belongs-with respect to metabolism-to the best-characterized Rickettsia species. This pathogen causes epidemic typhus (101) and multiplies in the cytosol of endothelial cells, the main host target cells (102) . The pathogenic mechanisms, including rickettsial entry into metabolically active host cells, phagosomal escape, propelling of the bacteria by polymerized actin tails through the injected host cell, and into neighbouring cells were mainly studied in R. conorii, which belongs to the spotted fever group (SFG) of Rickettsia species. This type of intra-and intercellular motility resembles that of Shigella and L. monocytogenes and was reviewed by Walker and Ismail (102) . R. prowazekii does not form actin tails, suggesting differences in the intracellular life cycle. Identification of rickettsial virulence factors and their precise functions are complicated by the lack of an effective genetic manipulation system for rickettsiae.
This failure also hampers conclusions concerning the metabolism of R. prowazekii when replicating within the endothelial target cells. The annotation of its highly reduced genome, encoding only 835 proteins (103) , suggests very limited catabolic and anabolic activities compared to those of Shigella and even of L. monocytogenes. The low intracellular growth rate of R. prowazekii (generation time about 10 h) (104) compared to growth rates of Shigella and L. monocytogenes (generation time about 1 h) seems to be consistent with this low metabolic capacity. Genes for the known glucose or glucose-6P-transporters, as well as for the enzymes of the glycolytic/gluconeogenic pathway and the pentose-phosphate pathway are missing, indicating that glucose or other carbohydrates cannot be used as carbon and energy sources and gluconeogenesis starting from gluconeogenic substrates is also not possible (Fig. 1c) . R. prowazekii can take up, however, uridine 5′-diphosphoglucose (UDPG), which may serve as precursor for the biosynthesis of the sugar components required for the synthesis of the cell envelope components peptidoglycan and LPS (105) . The rickettsial genome also carries the genes for the biosynthesis of mesodiaminopimelate (m-DAP) and for pyruvate phosphate dikinase required for PEP formation. Both, m-DAP and PEP are needed for peptidoglycan biosynthesis, and PEP in addition for the synthesis of 3-deoxy-Dmannooctulosonic acid (KDO) synthesis, a specific component of LPS. The rickettsial genome contains the genes encoding pyruvate dehydrogenase and all enzymes of the TCA cycle (Fig. 1c) . The TCA enzymes are functional (106) suggesting that (at least in principle) C 2 -(e.g., acetyl-CoA), C 3 -(e.g. pyruvate), C 4 -(e.g., malate or succinate), and C 5 -catabolic intermediates (e.g., glutamate/ oxoglutarate), possibly imported from the host cell's cytosol, can be oxidized in the TCA cycle. The thereby produced NADH/H + and FADH 2 may be used as electron donors that are transferred to the existing carriers of the electron transfer chain for ATP production by aerobic respiration (106) . R. prowazekii is also able to import ATP from the host via an ATP/ADP translocase (106) . It is likely that this dual energy supply mechanisms reflect the adaptation of R. rickettsia to the metabolic activity of the host cell.
R. prowazekii has also lost most genes for the biosynthetic pathways of vitamins, (purine and pyrimidine) nucleotide monophosphates (but retained the genes encoding the enzymes for the conversion of the mononucleotides to all other ribo-and deoxyribonucleotides), and amino acids (besides m-DAP, only biosynthesis of Ala, Glu, and Asp is possible by transamination of the corresponding catabolic intermediates). Biosynthesis of fatty acids and (in part) of phospholipids can, however, function (107) . The necessary sn-glycerol-3-phosphate which is not produced by R. prowazekii (due to the lack of the glycolytic and gluconeogenic pathways) seems to be imported from the host cell, probably by several existing rickettsial triose phosphate transport systems (108) . The existence of a large number of transporters for catabolic intermediates and anabolic monomers is indeed a hallmark of R. rickettsiae (105, (109) (110) (111) (112) . The hitherto poorly understood regulation of the rickettsial metabolite transporters in the course of the host cell infection is probably decisive for the balanced interaction of the host and the parasite since both partners compete, more or less, for the same nutrient pool. In this context, it has been proposed that the rickettsial transport systems might even be considered as metabolic virulence factors (108) .
Metabolic host cell responses triggered by intracellular R. prowazekii
Rickettsiae trigger a variety of responses in endothelial cells, including induction of many cytokines and chemokines, enhanced production of ROS and RNI, and the induction of cyclo-oxygenase-2 (COX-2) leading to secretion of prostanoids; reviewed in references 100 and 113. Although most of these host responses are aimed to protect the host, some may favor the rickettsial survival and proliferation, e.g., NF-kB induction, which inhibits host cell death by apoptosis and thus maintains the intracellular niche for R. prowazekii (114) . The rickettsial (virulence?) factors (including possible effectors secreted by the type IV secretion system (103)), responsible for the R. prowazekii-triggered host responses that may also affect the host cell metabolism, remain to be discovered.
Intracellular Bacterial Pathogens Replicating in Specialized Vacuoles
Salmonella enterica serovar Typhimurium (S. Typhimurium) Metabolic adaptations of intracellular S. Typhimurium
The virulence mechanisms of S. Typhimurium have been extensively reviewed in the past and will not be further discussed here; for recent reviews, see references 115-119. S. Typhimurium has a very robust metabolic equipment (Fig. 2a ) that allows these Gram-negative bacteria to grow (like Shigella) on many different glycolytic and gluconeogenic carbon sources and to produce all essential anabolic monomers (120) . It is therefore not surprising that these bacteria are also able to proliferate within a variety of host cells (121) where they primarily proliferate in the Salmonella-containing vacuole (SCV). They are also able to efficiently replicate in the cytosol of epithelial cells (14, 17) .
The intracellular metabolism of S. Typhimurium growing in cultured cells and model animals were studied using differential gene-expression profiling (DGEP), proteomics, and 13 C-isotopologue profiling (27, 122) . The DGEP studies, which compared the transcripts of intracellular S. Typhimurium cultured in epithelial and macrophage cell lines (HeLa and J774, respectively) with those of Salmonella grown in rich LB medium, show upregulation of the genes encoding enzymes for GL and ED and repression of most genes encoding the enzymes of the TCA cycle. Differential expression of these genes is more pronounced in HeLa than in J774 cells. From these studies, glucose, glucose-6P, and/or gluconate were suggested as probable carbon and energy source(s) for the intracellular metabolism of S. Typhimurium. 13 C-isotopologue profiling data showed that S. Typhimurium replicating in the SCV of Caco-2 cells (human intestinal cell line) uses glucose (but not glucose-6P) as preferential carbon substrate and incorporates 13 C-label from [U- 13 C 6 ]glucose very efficiently into amino acids, suggesting an extensive de novo synthesis of these monomers when S. Typhimurium grows in the SCV. A mutant, impaired in glucose uptake, was, however, still able to replicate (albeit at a significantly reduced growth rate) in Caco-2 cells indicating that S. Typhimurium can switch in the absence of glucose to other nutrients as carbon and energy sources, most likely to C 3 -substrates (65) , but the use of C 2 -substrate(s), deriving e.g., from fatty acids, could not be excluded by these studies.
Bowden and colleagues (123) analysed the replication of S. Typhimurium mutants, defective in glycolysis and glucose uptake, in J774 macrophages and also came to the conclusion that glucose represents the major carbon source and glycolysis is needed for efficient intracellular growth of S. Typhimurium in the SCV. The carbon metabolism of S. Typhimurium studied in systemically infected mice using S. Typhimurium wild-type and mutant strains (blocked in various steps of the primary carbon metabolism) seemed to depend on similar carbon substrates and catabolic pathways as shown by the cell culture studies discussed above (124) . The strong attenuation of mutants blocked in the biosynthesis of aromatic amino acids, including histidine and of purines (especially adenine), as well as the moderate attenuation of pyrimidine-and methionine-mutants observed in the infected mice, demonstrated the dependency of in vivogrowing S. Typhimurium on the biosynthesis of these anabolic monomers. The in vitro data supported this assumption: the DGEP studies also showed enhanced expression of the genes encoding enzymes for these anabolic pathways and, as already mentioned above, the On: Mon, 23 Apr 2018 01:33:47 13 C-isotopologue profiling results (65) demonstrated significant de novo synthesis of amino acids in S. Typhimurium growing in Caco-2 cells. However, it should be emphasized that these in vitro data were obtained with bacteria actively growing in the SCV of their host cells and hence do not exclude the possibility that at later time points (when glucose becomes limited for the host cells), the expected change in the host cell physiology may lead to significant changes in the metabolism of the intracellular bacteria, possibly associated with the release of S. Typhimurium from the SCV into the cytosol and the later egress from the infected host cell (16, 18, 38) .
Metabolic host cell responses triggered by intracellular S. Typhimurium
It is likely that effector proteins translocated by the TSS3 systems of S. Typhimurium-for a recent review, see (125)-act as modifiers of the host cell metabolism to support intracellular replication. As shown by Knodler and collegues (126), S.Typhimurium residing in the SCV translocates SopB which activates Akt, a central regulator of host cell carbon metabolism (127) . This activation occurs within minutes after invasion and lasts for several hours. Among others, activated Akt phosphorylates Mdm2, a key regulator of p53 stability. Activated Mdm2 ubiquitinates p53 and thus promotes p53 degradation, which may in turn stimulate glucose flux via glycolysis. The Akt activation also leads to inhibition of apoptosis of the infected host cells (126) , which is essential for Salmonella infection of epithelial cells and macrophages (128) . AvrA, another Salmonella T3SS-translocated effector protein (129) , might also be responsible, either directly or indirectly, for some of the specific Salmonella-induced metabolic host responses. As shown (130) , AvrA leads to reduction of oxidative phosphorylation and to activation of mTOR, NF-κB, and p53 in intestinal in vivo infection. The activation of p53 is caused by AvrA-mediated p53 acetylation (131) . While activated p53 will inhibit glycolysis, activated mTOR may stimulate amino acids uptake and catabolism. Thus, the AvrA-mediated activation of these regulators may again modify the carbon metabolism of Salmonella-infected host cells.
In a recent study, Lopez and colleagues showed that S. Typhimurium strains expressing the type III effector protein SopE (encoded by a lysogenic phage present in several epidemic strains) triggers the synthesis of iNOS in the host cells (22) . The thereby produced nitric oxide is converted to nitrate in the host cell which acts as an efficient electron acceptor in anaerobic nitrate respiration. Under these respiratory conditions, S. Typhimurium is able to use the non-fermentable carbon source ethanolamine (132), a nutrient deriving from phosphatidylethanolamine that is present in the intestine (133) . This metabolic capability generates a growth advantage for S. Typhimurium over the inherent anaerobic intestinal microbiota that is unable to respire ethanolamine.
Salmonella infection of murine macrophage-like cell lines (RAW264.7 and J774A.1) induced the expression of COX-2 (134) (135) . This induction depends on the Salmonella protein SpiC, a gene product encoded within SPI-2 and translocated into host cells by T3SS-2 (135). COX-2 encodes cyclooxygenase 2, a key enzyme involved in prostanoid synthesis, which leads to an increased production of PGE2 and PGI2, two prostanoids belonging to the eicosanoid hormones.
Legionella pneumophila (L. pneumophila) Metabolic adaptations of the intracellular L. pneumophila L. pneumophila, a Gram-negative bacterium, is the causative agent of Legionnaires' disease, a severe pulmonary disease (136) . The natural hosts of this microorganism are apparently amoebae (137) . By accident, L. pneumophila may also infect humans where it resides in alveolar macrophages. In these cells (and also in amoebae) the bacteria efficiently replicate within the socalled Legionella-containing vacuoles (LCV). The development of the LCV into a safe intracellular growth niche for L. pneumophila requires the remodeling of the LCV surface and the intimate interactions with ERderived vesicles and organelles (mitochondria and ribosomes) (138) . The close association with these vesicles and organelles may be important for the nutrient supply into the LCV. L. pneumophila actively replicates within the LCV for several hours after infection (replicative form, RF). Under nutrient limitation, the RF differentiates to the transmissive form (TF), which appears to be metabolically almost dormant, but expresses factors enabling the infection of new host cells. This biphasic lifestyle obviously requires specific metabolic adaptations in response to changing intracellular milieus (see below). The best-characterized virulence determinant is the Icm/Dot type IV secretion system, which may translocate about 300 effector proteins into the host cell cytosol (139) (140) . Several genes encoding effectors are highly expressed in L. pneumophila replicating in macrophages (141), indicating essential functions of these proteins for efficient replication within the LCV (142) (143) .
As for most other intracellular bacteria replicating in vacuoles, it is still rather unclear which nutrients are ASMscience.org/MicrobiolSpectrumrequired for the intracellular metabolism of the RF and TF forms of L. pneumophila, how these nutrients are shuffled into the LCV, and which pathways are used to catabolize these compounds. The genome of L. pneumophila (144) contains all genes for the enzymes of the glycolytic pathway, the ED pathway, the TCA cycle, and the PPP, but typical PTS permeases for the import of glucose or other carbohydrates are missing (Fig. 2b) . The genes fbp and pck, encoding fructose-1,6-bisphosphatase (FBP) and phosphoenolpyruvate carboxykinase (PCK), respectively, i.e., enzymes involved in gluconeogenesis, seem also to be absent. This is unexpected since gluconeogenesis should function as L. pneumophila is able to grow in defined culture media with gluconeogenic substrates (such as amino acids) as sole carbon sources (145) . The genes for the biosynthetic pathways of Cys, Met, Thr, Val, Ile, and Leu are missing or incomplete in L. pneumophila, which is in accord with the lack of de novo synthesis of these amino acids under in vitro culture conditions (146) .
Using Acanthamoeba castellanii as host for L. pneumophila, Brüggemann and collegues (147) could show that-in addition to genes involved in amino acid catabolism-genes encoding a putative sugar transporter, a putative glucokinase, and the enzymes of the ED pathway are upregulated in the actively growing (RF) bacteria, suggesting that-in addition to amino acidshexoses (presumably glucose or glucose-6P) may be used as carbon substrates for intracellular growth of L. pneumophila. However, recent studies (148) feeding external 13 C-glucose to A. castellanii infected with (RF) L. pneumophila suggested that glucose is not a major nutrient for providing precursors for de novo synthesis of bacterial amino acids. Nevertheless, these data do not rule out that glucose-6P, rather than glucose, is an essential carbon substrate taken from the host cell. Indeed, L. pneumophila carries an uhpC gene that is highly homologous to the uhpC gene of Chlamydia pneumoniae. The chlamydial UhpC has been shown to function as a glucose-6P transporter (149) .
Amino acids (especially Ser, Thr, and Glu) may serve as major carbon, nitrogen, and energy sources for L. pneumophila when actively replicating in defined culture media or in macrophages (146, (150) (151) (152) . The presence of genes for several other amino acid and peptide transporters, peptidases, and proteases in the L. pneumophila genome supports this finding. Indeed, the transcription profiles of in vitro grown, RF (compared to TF) L. pneumophila showed significant upregulation of genes encoding amino acid transporters, amino acid-degrading enzymes (especially for serine and threonine), and several aminopeptidases and proteases (153) . A recent transcriptome analysis (141) , which compared the transcripts of intracellular L. pneumophila (replicating in human macrophage-like THP-1 cells) and of extracellular L. pneumophila (growing in AYE broth), also showed upregulation of many genes encoding transporters for amino acid and oligopeptides, as well as for enzymes involved in degradation of Lys, Arg, His, Thr, Glu, and Gln. Enhanced expression of genes encoding enzymes that are involved in glycerol catabolism was also observed, suggesting that not only amino acids but also glycerol could be used as a carbon source under intracellular growth conditions. The upregulation of the genes encoding phosphoenolpyruvate carboxylase and pyruvate carboxylase, respectively, supports this assumption as both enzymes connect glycerol catabolism with the TCA cycle by converting PEP and pyruvate, respectively, to oxaloacetate. This TCA intermediate is also a precursor in Asp and Lys biosynthesis. The genes for the biosynthesis of these two amino acids (as well as for His, Arg, and Pro) were also found to be induced. However, it remains to be elucidated whether the induction of the latter genes is really essential for intracellular growth of L. pneumophila or simply caused by de-repression due to the probably much lower levels of these amino acids within the host cells compared to the AYE medium.
The TF form of L. pneumophila contains substantial amounts of poly-3-hydroxybutyrate (PHB). PHB represents a bacterial energy and carbon storage compound and its degradation (leading to acetyl-CoA) in the TF stage may be important for maintaining the intracellular growth cycle of L. pneumophila. Indeed, a mutant defective in PHB metabolism showed a severe replication defect in amoebae and macrophages (154) .
Together, these findings provide evidence that L. pneumophila uses-in addition to amino acids-carbohydrate (s), possibly including glucose-6P and glycerol as carbon sources for growth, at least in the late phase of intracellular growth. The carbohydrate(s) seem to be catabolized by ED and PPP rather than by GL (146) . In line with this assumption is the finding that a Δzwf mutant of L. pneumophila lacking glucose-6P dehydrogenase, an enzyme required for entering the ED pathway, is outcompeted by the isogenic wild-type strain after several rounds of infection in A. castellanii, although the replication rate of this mutant is not significantly altered (146) . This indicates that carbohydrate(s) providing glucose-6P are necessary for the host-adapted intracellular metabolism of L. pneumophila, possibly for anabolic processes (e.g., for the synthesis of the sugar components of peptidoglycan and LPS). Indeed, a glucoamylase-like enzyme of L. pneumophila was shown to exhibit glycogen-and starch-degrading activity (155) .
Metabolic host cell responses triggered by intracellular L. pneumophila
There are several lines of evidence indicating that L. pneumophila specifically manipulates the host cell's metabolism in favor of its proliferation. The amino acids transporter SLC1A5 (specific for neutral amino acids) was highly induced in the human monocyte cell line MM6 upon infection by L. pneumophila and was shown to be important for bacterial proliferation in these host cells (156) . Preliminary evidence suggests that SLC1A5 is translocated to the LCV membrane thus supporting the uptake of cysteine, serine, glutamine, and other amino acids into the LCV. L. pneumophila effector proteins translocated by the T4SS into the host cells might be indirectly or even directly involved in the modification of metabolic processes of the infected host cells that support the intracellular metabolism of L. pneumophila, e.g., by provision of amino acids (157) (158) (159) (160) (161) .
L. pneumophila-infected human macrophage-like U937 cells activated NF-κB signaling in a Dot/Icmdependent manner (162) by the effector protein LnaB (163) . NF-κB, well-known as an important regulator of eukaryotic cell survival and differentiation, is also linked to metabolic processes, e.g., glutamine metabolism (164) . Putative Dot/Icm-dependent serine/threonine protein kinases and phosphatases may also modulate the activity of metabolic enzymes, as well as host-signaling pathways and possibly downstream metabolic processes (144, (165) (166) .
Chlamydia trachomatis (C. trachomatis) Metabolic adaptations of intracellular C. trachomatis
The genus Chlamydia comprises obligate-intracellular, closely related, pathogenic species. The two major human pathogens, C. trachomatis and C. pneumoniae, cause infectious blinding trachoma or sexually transmitted disease and a community-acquired pneumonia, respectively (167) (168) . During these infections, the pathogens mainly grow in epithelial cells of the urogenital and the respiratory tract, respectively. After entry into host cells, the chlamydiae replicate in a specialized vacuole, termed "inclusion" (169) where they may exist in two morphologically and functionally distinct forms: the replicative, noninfectious, reticulate bodies (RB) and the elementary bodies (EB), which is infectious, but has a highly reduced metabolism (170) (171) (172) . The residual metabolic activity of EB, including uptake and catabolism of glucose-6P, seems to be important for maintaining the EB infectivity of C. trachomatis (172) . EB are released from the infected cells and may exist in a non-replicative extracellular state. The conversion of RB to EB occurs within the inclusion that-similar to the above described LCV-can fuse with ER-and Golgiderived vesicles. This fusion leads to the acquisition of glycerophospholipids and sphingolipids from the vesicles, which increases the inclusion-membrane surface, and appears to be essential for intracellular growth of C. trachomatis (173) (174) by assisting import of hostderived, high-energy metabolites and nutrients (which chlamydiae are unable to synthesize, see below) (175) . Furthermore, the Chlamydia species may exist in a metabolically and morphologically aberrant RB-like persistent state (176) .
C. trachomatis and C. pneumoniae have highly reduced genomes (1.2 Mb or less). Several genes involved in the central carbon and energy metabolism and most genes for anabolic pathways and regulatory factors are missing (177) (178) . However, these Chlamydia species carry the genes for all enzymes of GL and PPP, whereas the genes for the TCA cycle are incomplete in both pathogenic species (Fig. 2c) , lacking the genes encoding the enzymes that catalyse the reactions from oxaloacetate to oxoglutarate. Similarly, as in rickettsiae, chlamydial genes (adt) encoding two ATP/ADP exchange proteins were identified (179) (180) (181) , suggesting that ATP can be imported from host cells. The pathogenic Chlamydia spp. lack the genes for most cytochromes and flavoproteins of the electron-transfer chain and also for the F 1 ,F 0 -ATP synthase (catalyzing H + -driven ATP synthesis), but retained cydA and cydB, encoding the cytochrome bd oxidase. The main bioenergetic function of this enzyme is the generation of a proton-motive force (PMF) by the vectorial charge transfer of protons. The genomes contain the genetic information for the subunits of a V-type ATPase that may likewise transport H + out of the bacterial cell at the expense of ATP. Hence, these reactions might be important for PMF-dependent transport processes (177) .
The expression of adt, cydA, and cydB; pyk, gap, pgk, and gnd; tal, fumC, and mdhC, encoding glycolytic, PPP, and TCA enzymes, respectively, was demonstrated in C. trachomatis-infected Hep-2 cells in the active replicative phase, suggesting that during active growth the chlamydial energy requirement is met by ATP import from the host and by its own ATP production via the active glycolytic pathway. In persistent C. trachomatis bacteria (growing in human monocytes), only adt1, cydB, fumC, and mdhC transcripts were identified, suggesting that in this state ATP may also be taken primarily from the host cells (182) .
On the other hand, proteome analyses detected the entire set of predicted glycolytic and PPP enzymes in C. trachomatis EB cells. These data suggest that the metabolic flux through these pathways, rather than de novo synthesis of the enzymes involved in these catabolic pathways, is induced when chlamydiae infect and actively replicate in the host cells (183) . This hypothesis is also in line with the recent finding that some glucose catabolism may even occur in EB (5, 172) . Furthermore, cell culture experiments using different carbon sources show that chlamydiae-unlike most free-living bacteriado not alter the expression of genes involved in carbon metabolism in response to nutritional changes (184) . Together, these data suggest that the expression of chlamydial genes encoding the enzymes involved in carbon catabolism is constitutive and little modified by the interaction of chlamydiae with the host cells, a conclusion that is consistent with the apparent lack of all global regulators known to control metabolic genes in bacteria.
What are the major carbon sources for the intracellular chlamydiae? As discussed above, ATP production by substrate-level phosphorylation seems to occur in RB during the active growth phase, suggesting the use of carbon substrates, such as carbohydrates including glycerol or glycerol-3P, that are oxidized in the ATPdelivering reactions of the lower part of the glycolytic pathway. Glucose transporters have not yet been identified in the pathogenic Chlamydia species. Indeed, 13 C-isotopologue studies using uniformly labeled 13 Cglucose provided to C. trachomatis-infected Caco-2 or HeLa cell cultures showed no significant glucose catabolism by the intracellular chlamydiae (A. Mehlitz, T. Rudel, W. Goebel, and W. Eisenreich, unpublished data). However, the uhpC gene present in all chlamydiae encodes a functional glucose-6P transporter (149), suggesting that imported glucose-6P may not be catabolized but rather serve as substrate for anabolic processes, e.g., biosynthesis of cell envelope components or production of glycogen. A chlamydial glycogen synthase (GlgA) has been identified which is secreted into the lumen of the inclusion and even into the cytosol of infected cells (185) . C. trachomatis also has a functional glycogen phosphorylase and it has been suggested that glycogen might serve as a source for the generation of phosphorylated glucose at a later stage (183) .
The protease CPAF shows a similar secretion pattern as GlgA (185) . The action of this protease may be essential for providing host amino acids for chlamydial protein biosynthesis. Indeed, C. trachomatis seems to be totally dependent on the import of all amino acids from the host cell. However, with the exception of glutamate, the imported amino acids did not seem to be catabolized as shown by 13 C-isotopologue analysis (A. Mehlitz, personal communication). Glutamate appears to be channeled via oxoglutarate into the residual TCA cycle where it is converted to oxaloacetate providing NADH/H + , FADH 2 , and GTP. The residual TCA cycle could be also fed by host-derived succinate or malate since a dicarboxylate translocator has been identified, even in EB of C. trachomatis (183) . The production of oxaloacetate (as precursor of aspartate) might be important for the biosynthesis of meso-2,6-diaminopimelate (m-DAP). The m-DAP pathway is complete in chlamydiae (as in all peptidoglycan-containing bacteria).
Oxaloacetate may be also converted to PEP via PCK. The pckA gene encoding PCK is present on the chlamydial genome and the chlamydial PCK protein was identified by proteome analysis (183) . This enzyme is essential for gluconeogenesis starting from TCA intermediates. Nevertheless, it remains questionable whether gluconeogenesis functions in chlamydiae, since a fbphomologous gene, encoding the necessary FBP, has not been identified in C. trachomatis. However, the situation is similar in L. pneumophila, where an atypical FBP (186) must be present as gluconeogenesis should be functional since the bacteria are apparently able to grow with amino acids as the sole carbon source (145) . In this context, it might be worthwhile to note that the reverse reaction leading to the formation of FBP by the glycolytic enzyme 6-phosphofructokinase (PFK) also seems to be catalyzed by atypical PFK(s) (187) . Two enzymes (PFK-1 and PFK-2) are annotated in C. trachomatis (Kyoto Encyclopedia of Genes and Genomes [KEGG] GENES database) (206) with little homology to the classical ATP-PFKs from bacteria and eucarya and, to our knowledge, a biochemical PFK function has not been shown for either PFK-1 or PFK-2.
The capacity of chlamydiae for production of anabolic components is very limited. The two humanpathogenic Chlamydia species lack the genes for the biosynthesis of vitamins, purines, pyrimidines, and almost all amino acids. Hence, chlamydiae rely entirely on the import of these essential metabolites from the host cell. Several genes encoding transporters for purine and pyrimidine have been identified in the chlamydial genomes (177) . In addition, chlamydiae possess a transporter for all four ribonucleoside triphosphates (188) . Amino acids are mainly provided by the host cell through lysosomal degradation of external proteins (12) or through protein degradation by the chlamydial proteases, CPAF and cHtrA, that are secreted into the host cells cytosol (189) (190) (191) . As expected, the chlamydiae possess several genes encoding amino acid transporters (177) . The only amino acids that can be made de novo are those that simply need transamination of catabolic intermediates (Ala, Asp, and Glu) and mesodiaminopimelate (m-DAP) (177) (A. Mehlitz, personal communication). The entire gene set for the biosynthesis of m-DAP essential for peptidoglycan synthesis is present, whereas the subsequent gene for the diaminopimelate decarboxylase leading to Lys is missing. Indeed, all sequenced chlamydial genomes reveal the genetic information for peptidoglycan biosynthesis, although previous studies (192) could not detect peptidoglycan in chlamydial EB.
All aro genes necessary for the biosynthesis of chorismate-probably used for the synthesis of quinonesare also present. C. trachomatis, but not C. pneumonia, has also retained the genes trpA and trpB, encoding tryptophan synthetase (but not the other genes involved in tryptophan biosynthesis). The presence of this enzyme could allow the recycling of tryptophan precursors (especially indole) to tryptophan (193) and may constitute a selection advantage under conditions where host cell tryptophan is degraded, e.g., upon IFN-γ induction (194) . Indeed, tryptophan starvation of Chlamydiainfected HEp-2 cells, mediated by IFN-γ treatment, blocks the conversion of the RB to the infectious EB form, which is normally induced by amino acid starvation. In addition to the de novo chlamydial fatty acid and (partial) phospholipid biosynthesis, host cell-derived phospholipids and sphingolipids required for the intracellular growth can also be trafficked and modified by chlamydiae (173, (195) (196) .
Metabolic host cell responses triggered by intracellular C. trachomatis
Chlamydial infections lead to increased glucose uptake and glucose flux through the glycolytic pathway of the infected host cells (197) (198) . Induction of the pentosephosphate shunt is also observed, which may be linked to the enhanced anabolic performance (increased protein and lipid synthesis) observed in the host cells during the proliferative phase of the chlamydiae. The remarkable up-regulation of many genes encoding transporters for nutrients needed for intracellular chlamydial growth (199) suggests increased import of these nutrients by the host cells and the possible recruitment of these nutrient transporters to the membrane surrounding the Chlamydia-containing inclusion. The pathogenic chlamydiae possess a type III secretion system (200) (201) and various effector proteins essential for virulence (169, 202) . But up to now, it is unknown whether some of these effectors may also trigger metabolic host responses observed in chlamydial infections.
CONCLUSIONS
The group of intracellular bacterial pathogens comprises microorganisms with highly different metabolic capacities. But, in each case, a successful intracellular pathogen adapts its intracellular metabolism to the metabolism of the infected host cell, triggers favorable metabolic host cell responses, and coordinates the expression of the genes encoding virulence factors needed for the intracellular bacterial life cycle, with its intracellular metabolism, in order to achieve efficient replication and to prevent premature death of the host cell. Common and pathogen-specific factors are apparently involved in this bilateral metabolic adaptation process (termed "pathometabolism"). Although our knowledge on the precise mechanisms responsible for these processes is still rather limited (27, 30) , the available data suggest that the intracellular bacteria have apparently evolved individual strategies for this metabolic pathogen/host cell relationship, as outlined above for some selected examples. Since the final aim of this interaction is the optimal proliferation of the intracellular pathogen at the expense of the host cell, this interaction will be always parasitic.
Within the different individual strategies of the pathogens some common motifs are, however, recognizable, which concern in particular the handling of essential nutrients to insure extended survival of both partners. The use of more than one carbon source captured from the host cells by the intracellular bacteria seems to be a general mode for generating the necessary energy and metabolic intermediates to perform the indispensable bacterial biosynthesis of cell envelope components, of nucleic acids, and of proteins without harming the host cell too much. The choice and combination of the carbon sources used by the particular pathogen apparently depend on the metabolic capabilities of the pathogen and on the infection-adjusted host cell metabolism.
For those intracellular pathogens that possess redundant catabolic and anabolic capacities, the sequence of the preferentially used carbon sources may be adapted to the threshold concentration of the respective carbon substrate in the host cell. In this case each carbon substrate used may deliver both energy and intermediary metabolites, but the rate of the bacterial proliferation, and probably also the expression of virulence factors and the fate of the host cell, will depend on the choice of the actually used carbon source.
Most of the well-adapted intracellular pathogens have incomplete catabolic and, particularly, anabolic pathways and for these bacteria the simultaneous use of more than one carbon substrate might be necessary for producing enough energy and metabolic intermediates to guarantee bacterial proliferation. In this case, the availability of only a single carbon source may lead to a highly reduced metabolism providing just enough energy for the survival of the bacteria in a metabolically almostdormant state in which the intracellular bacteria must still be at least able to carry out energy-requiring vital repair functions (in particular, DNA repair).
These co-metabolism strategies might also reduce the metabolic burden put on the host cell by the infection with intracellular pathogens and extend the host cell's lifespan-also to the advantage of the pathogen. Common and, in particular, pathogen-specific factors may support this metabolic pathogen/host cell relationship by inducing uptake and catabolism of basic nutrients (e.g., glucose or glutamine) by the host cell, and by silencing antimicrobial metabolic host cell reactions (30) .
Another common strategic motif concerns the acquisition of host cell amino acids (and possibly other essential anabolic monomers) by the intracellular bacterial pathogens. Import of host cell amino acids is observed even when the intracellular bacteria are prototrophic for all amino acids. The extent of amino acid import seems to depend on the available carbon source, i.e., import is low and bacterial de novo amino acid synthesis is high when an energy-rich carbon compound, e.g., glucose, is used and vice versa when a less energy-rich carbon source, e.g., glycerol, is utilized. This strategy is consistent with the view that biosynthesis of most amino acids is energetically more costly for intracellular bacteria than import of these amino acids from the host cell and implies that the efficiency of intracellular bacterial replication will be significantly affected by the pool of free amino acids (and/or oligopeptides) in the host cell. This pool is mainly determined by the uptake of external amino acids or by stimulation of internal protein degradation (especially through the proteasomal machinery and autophagy), host cell processes that may be again induced by bacterial (virulence) factors (160, 203) .
In this context, an interesting hypothesis has been proposed recently (38) postulating that Cys (the most limiting amino acid in mammalian cells) (204) or other limiting essential amino acids might function as nutritional rheostats controlling the proliferation of intracellular pathogens. Indeed, many intracellular pathogens are unable to synthesize Cys (including L. monocytogenes, R. prowazeki, L. pneumophila, and C. trachomatis among those discussed here) and hence completely rely on Cys supply from the host cell. Pathogen-specific strategies have been evolved to cope with the bottle neck of Cys supply (160, 205) . Possibly, other vital anabolic monomers may play a similar role as Cys in controlling the intracellular metabolism of bacterial pathogens (152) .
In summary, the ability of an intracellular bacterial pathogen to adapt its own metabolism to the intracellular milieu of the host cell, to modulate the host cell metabolism in favor of its own needs with the help of common and pathogen-specific (virulence) factors, and to adjust the expression of the necessary virulence genes to the intracellular metabolism, must be viewed to be central for the pathogenesis of infections by intracellular bacterial pathogens. For the complex metabolic interconnection between bacterial pathogens and host cells, we have introduced the term "pathometabolism."
